pyridine has been researched along with alpha-synuclein in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Hirohata, M; Ono, K; Yamada, M | 1 |
Dardou, D; Durif, F; Fleurance, R; Gryshkova, V; Hafidi, A; Loiodice, S; McGhan, P; Nogueira da Costa, A | 1 |
Manglano-Artuñedo, Z; Outeiro, TF; Peña-Díaz, S; Pinheiro, F; Pujols, J; Santos, J; Vasili, E; Ventura, S | 1 |
3 other study(ies) available for pyridine and alpha-synuclein
Article | Year |
---|---|
Anti-fibrillogenic and fibril-destabilizing activity of nicotine in vitro: implications for the prevention and therapeutics of Lewy body diseases.
Topics: alpha-Synuclein; Benzothiazoles; Humans; Kinetics; Lewy Body Disease; Microfibrils; Microscopy, Atomic Force; Microscopy, Electron; Mutation; Nicotine; Nicotinic Agonists; Pyridines; Pyrrolidines; Reverse Transcriptase Polymerase Chain Reaction; Spectrometry, Fluorescence; Thiazoles | 2007 |
Striatal changes underlie MPEP-mediated suppression of the acquisition and expression of pramipexole-induced place preference in an alpha-synuclein rat model of Parkinson's disease.
Topics: alpha-Synuclein; Animals; Benzothiazoles; Corpus Striatum; Dopamine; Excitatory Amino Acid Antagonists; Impulsive Behavior; Male; Nucleus Accumbens; Parkinson Disease; Pramipexole; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Glutamate; Up-Regulation | 2017 |
The small aromatic compound SynuClean-D inhibits the aggregation and seeded polymerization of multiple α-synuclein strains.
Topics: alpha-Synuclein; Amyloid; Humans; Lewy Bodies; Neuroprotective Agents; Parkinson Disease; Polymerization; Protein Aggregation, Pathological; Pyridines; Synucleinopathies | 2022 |